Follow-up study of patients with polycystic ovary syndrome for predicting risk factors of cardiovascular disease

Not Applicable

Completed

• Conditions: Endocrine, nutritional and metabolic disease

• Registration Number: KCT0000739
• Lead Sponsor: Korea Centers for Disease Control and Prevention

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 11 March 2019

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 200

Inclusion Criteria

1. Age:18-40
2. Oligo or anovulation
: menstrual cycle length in excess of 35 days or less than 8 cycles per year or absence of menstruation for more than 3 months
3. Clinical or biochemical hyperandrogenism
: clinical HA (modified Ferriman-Gallwey score of more than 6)
or biochemical HA (total testosterone >0.68 ng/mL or free T >1.72 pg/mL or free androgen index >5.36)
4.Polycystic on ultrasound
: 12 or more follicles measuring 2-9 mm in diameter in each ovary and/or enlarged ovarian volume(10?)

Exclusion Criteria

1. Exclusion of related disorders such as ovarian deficiency symptom, Hypothyroidism, Hyperprolactinemia, Congenital adrenal hyperplasia
2. Subjects who refuse to participate in this study
3. Subjects with use or oral contraceptives in the previous 1 month

Study & Design

• Study Type: Observational Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hypertension ;Dyslipidemia;insulin resistance ;Impaired glucose tolerance ;Metabolic syndrome;Obesity

Secondary Outcome Measures

Name	Time	Method
Cardiovascular disease risk factor